IREN Budgets $25 Billion To $30 Billion For Its AI Build-Out — More Than Its Entire $13.9 Billion Market Value
IREN stock has plunged 54% from highs earlier this year.
IREN stock has plunged 54% from highs earlier this year.
A Form 4 shows three trust accounts sold 96,992 shares on Wednesday, the fourth sale in her five latest filings.
The Boston antibody developer's S-1 leaves price and share count blank and says $71.5 million in cash may not last a year.
The second amended filing sets an exchange ratio range, a 12-seat board and a $2.5 billion Treeline value against $460 million for Standard BioTools.
The European Commission picked the Greek copper-gold mine under its Critical Raw Materials Act, the company said in a statement.
McDonough told AutoZone's board she will not stand for reelection after taking a new executive job whose calendar conflicts with board meetings.
The refinancing is expected to raise Integra's effective interest rate near the top of the range management flagged earlier.
An 8-K shows Tiffany Norwood and Kelle Wendling left the board Tuesday; Sidus Space says it disagrees with their letters.
Live Nation says swaps on its dollar notes put the blended rate at about 5.89%, against 6.500% on the 2027 notes it will redeem.
A KKR-affiliated holder agreed to buy 40 million shares, and underwriters took up their full 12 million-share option on Friday.
Amendment No. 8 to a Schedule 13D reports the lock-up only; the holders did not buy shares and their position is unchanged since June.
James Dolan's Form 3 lists 100 shares held through Madison Square Garden Sports and its subsidiaries, and he disclaims ownership.
Earnings
The Permian producer expects a $97 million cash loss on derivative settlements, plus an $85 million non-cash loss, for the quarter.
Earnings
Fiscal 2026 net income rose 6% on lower overhead, while higher manufacturing and freight costs cut gross margin from 29.5%.
Earnings
Irwin Simon laid out what Tilray would do if U.S. reform comes, if hemp drinks open up, or if nothing changes, while reaffirming guidance.
Earnings
The lender funded $162.0 million at cost in the quarter and held about $2.1 billion across 86 companies, with 92.6% in first lien debt.
Earnings
PepsiCo now expects 2026 core EPS growth of 2.5% to 3.5%, down from the low end of 5% to 7%, after a July call that blamed gas prices for a convenience-store slump.
Earnings
The CEO change came with first-quarter revenue of $80.9 million and unchanged full-year guidance, the company said on its earnings call.
Earnings
The clinical research company will hold a webcast on October 28, with a replay posted about an hour after the call ends.
Earnings
The gold developer reported a $36.0 million third-quarter loss and said professional fees tied to the Donlin Gold purchase will stay high into early fiscal 2027.
Earnings
The company will hold a webcast call at 8:00 am ET the same day, with a replay running to November 12.
Earnings
Med Tech sales rose 13.2% in the fiscal first quarter, and the company reiterated its full-year outlook ahead of a November 2 CEO handover.
Earnings
Ronald South stays through the third-quarter earnings process before moving to a senior advisory role on November 4.
Earnings
Tilray reported a $40.0 million first-quarter net loss on higher sales and reaffirmed its $68 million to $75 million adjusted EBITDA forecast.